Press Releases (Page 85)
2024 Law Firm Hourly Rate Report 2024: Rates Will Rise 7 - 9% in 2024 as Consolidation Among Large Law Firms Concentrates Expertise, Shrinking Market Supply
Dublin, Oct. 11, 2024 (GLOBE NEWSWIRE) -- The "Valeo 2024 Law Firm Hourly Rate Report" report has been added to ResearchAndMarkets.com's offering. The 2024 Law Firm Hourly Rate Report is the most comprehensive and detailed competitive intelligence and legal pricing tool available. The report details average hourly rates by individual law firms as opposed to aggregate groupings of law firms with disparate pricing structures as is... ❯❯❯
Community Associations Institute Seeks Preliminary Injunction Against Corporate Transparency Act
Motion hearing today in pending lawsuit aims to halt enforcement of the act for community associations.Falls Church, Va., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Today, the United States District Court for the Eastern District of Virginia will hold its first hearing in the case of Community Associations Institute, et al. v. Janet Yellen, et al. Community Associations Institute, the leading international authority on the community associatio... ❯❯❯
EXTR INVESTOR NEWS: Extreme Networks, Inc. Investors that Suffered Losses are Encouraged to Contact BFA Law before Expiration of October 15 Class Action Deadline (Nasdaq:EXTR)
NEW YORK, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Extreme Networks, Inc. (NASDAQ: EXTR) and certain of the Company’s senior executives. If you invested in Extreme, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/extreme-networks-inc. Investors have until October 15, 2024 to ask... ❯❯❯
ELAN INVESTOR NEWS: Elanco Animal Health Investors that Suffered Losses are Encouraged to Contact BFA Law before Expiration of December 6 Class Action Deadline (NYSE:ELAN)
NEW YORK, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elanco Animal Health Incorporated (NYSE:ELAN) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Elanco, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/ela... ❯❯❯
DXCM INVESTOR NEWS: DexCom, Inc. Investors that Suffered Losses are Encouraged to Contact BFA Law before Expiration of October 21 Class Action Deadline (Nasdaq:DXCM)
NEW YORK, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against DexCom, Inc. (NASDAQ: DXCM) and certain of the Company’s senior executives. If you invested in DexCom, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/dexcom-inc. Investors have until October 21, 2024 to ask the Court to be... ❯❯❯
$60 Billion Litigation Funding Investment Market Outlook, 2037: Includes Strategic Analysis of Burford Capital, Omni Bridgeway, Therium Group, GLS Capital, Validity Finance, Parabellum Capital & More
Dublin, Oct. 11, 2024 (GLOBE NEWSWIRE) -- The "Global Litigation Funding Investment Market 2037" report has been added to ResearchAndMarkets.com's offering.The global market for litigation funding investment is set to rise at a CAGR of 11.1% over the forecast period., 2025-2037. This growth of the market is poised to be encouraged by growing legal disputes and surging litigation funding by the number of litigate funders.Moreover,... ❯❯❯
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Outset Medical, Starbucks, Endava, and Sage and Encourages Investors to Contact the Firm
NEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Outset Medical, Inc. (NASDAQ: OM), Starbucks Corporation (NASDAQ:SBUX), Endava PLC (NYSE: DAVA), and Sage Therapeutics, Inc. (NASDAQ: SAGE). Stockholders have until the deadlines below to petition the court to serve as lead... ❯❯❯
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Orthofix, Spire Global, DexCom, and Methode Electronics and Encourages Investors to Contact the Firm
NEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Orthofix Medical Inc. (NASDAQ: OFIX), Spire Global, Inc. (NYSE:SPIR), DexCom, Inc. (NASDAQ: DXCM), and Methode Electronics Inc. (NYSE: MEI). Stockholders have until the deadlines below to petition the court to serve as lead... ❯❯❯
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AMMO, Iris Energy, and Terran and Encourages Investors to Contact the Firm
NEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of AMMO, Inc. (NASDAQ: POWW), Iris Energy Limited (NASDAQ: IREN), and Terran Orbital (NYSE: LLAP). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each... ❯❯❯
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GitLab, Agenus, ZoomInfo, and Super Micro and Encourages Investors to Contact the Firm
NEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of GitLab Inc. (NASDAQ: GTLB), Agenus Inc. (NASDAQ: AGEN), ZoomInfo Technologies Inc. (NASDAQ: ZI), and Super Micro Computer, Inc. (NASDAQ: SMCI). Stockholders have until the deadlines below to petition the court to serve as... ❯❯❯